Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Participants were randomized to tirzepatide 5mg, 10mg, or 15mg, or placebo, administered weekly for 72 weeks
Patients currently using AOM tirzepatide may need to switch to AOM semaglutide to maintain insurance coverage of the medication, while those wishing to remain on AOM tirzepatide may face higher out-of-pocket costs or coverage denials
Arenas J, Huertas R, Campos Y, Diaz AE, Villalon JM, Vilas E
It does not predict response to any specific medication and does not recommend a dose
Vietnam Glutathione Market Size and Forecast, by Product Type (2025-2032) 7.4.8.2
SURMOUNT-1 (72-week randomized study, adults without diabetes): tirzepatide produced an average loss of 15.0% (5 mg dose), 19.5% (10 mg dose), and 20.9% (15 mg dose) of body weight, versus 3.1% with placebo, under a similar lifestyle-intervention protocol
US$ 23.43
US$ 23.22
US$ 22.99
US$ 27.77
US$ 21.01
US$ 23.21
US$ 29.65
US$ 23.63
